LoadingLoadingLoading27 funds hold it.Insiders net selling.
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results
AqrQ2 2026 13F$19.8MAqrQ1 2026 13F$6.9M13F: filed up to 45 days late.
Each bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
AQR
$19.8M
added
AQR
$6.9M
added
No tracked top-trader positions in ABM as of Oct 27, 12:16 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Sep 8, 2026
Period ending
Jul 31, 2026
Earnings per share
$1.01 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 8, 2026 | $1.04 / $1.01Alpha Vantage | +2.97% beat | $2.32B No estimate | Unavailable |
| Apr 30, 2026 | Jun 5, 2026 | $0.90 / $0.88Alpha Vantage | +2.27% beat | $2.29B No estimate | Unavailable |
| Jan 31, 2026 | Mar 10, 2026 | $0.83 / $0.87Alpha Vantage | -4.60% miss | $2.24B No estimate | Unavailable |
| Oct 31, 2025 | Dec 17, 2025 | $0.88 / $1.09Alpha Vantage | -19.27% miss | $2.30B No estimate | Unavailable |
| Jul 31, 2025 | Sep 5, 2025 | $0.82 / $0.95Alpha Vantage | -13.68% miss | $2.22B No estimate | Unavailable |
| Apr 30, 2025 | Jun 6, 2025 | $0.86 / $0.86Alpha Vantage | +0.00% in line | $2.11B No estimate | Unavailable |
| Jan 31, 2025 | Mar 12, 2025 | $0.87 / $0.78Alpha Vantage | +11.54% beat | $2.11B No estimate | Unavailable |
| Oct 31, 2024 | Dec 18, 2024 | $0.90 / $0.87Alpha Vantage | +3.45% beat | $2.18B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.30B | $2.24B | $2.29B | $2.32B |
| Cost of what it sold | $2.04B | $2.00B | $2.01B | $2.03B |
| Gross profit | $257.5M | $248.1M | $277.0M | $286.1M |
| What it spent | ||||
| Sales and admin | $176.0M | $169.8M | $171.1M | $171.3M |
| Other operating costs | — | — | $19.0M | $23.3M |
| Total operating expenses | $176.0M | $169.8M | $190.1M | $194.6M |
| What was left | ||||
| Operating profit | $81.5M | $78.3M | $86.9M | $91.5M |
| Interest on debt | $24.3M | $24.0M | $28.1M | $29.5M |
| Profit before tax | $45.3M | $52.1M | $59.7M | $63.2M |
| Tax | $10.5M | $13.4M | $16.6M | $13.5M |
| Net profit | $34.8M | $38.8M | $43.1M | $49.7M |
| EBITDA | $96.3M | $101.8M | $116.1M | $123.3M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
